Dicerna Pharmaceuticals Inc (DRNA)
Common Stock
Eli Lilly Just Lent Its Big Pharma Cachet To Verve's Nascent Gene-Editing Program For $60 Million
Eli Lilly inked a deal worth $60 million to get in on a gene-editing drug for elevated lipoprotein A.
Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition
Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire Dicerna
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - ROG, PAE, MNTV, CSPR, VLY, DRNA
/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Rogers Corporation (NYSE: ROG)...
SHAREHOLDER ALERT: WeissLaw LLP Reminds VG, DRNA, DVD, and COR Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADTN, ROG, VG, DRNA; Shareholders are Encouraged to Contact the Firm
/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: ADTRAN, Inc. (NASDAQ: ADTN)...
SHAREHOLDER ALERT: WeissLaw LLP Reminds STXB, DRNA, DVD and VSAT Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CONE, VLY, DRNA, CSPR; Shareholders are Encouraged to Contact the Firm
/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: CyrusOne Inc. (NASDAQ: CONE)...
SHAREHOLDER ALERT: WeissLaw LLP Reminds DRNA, IHC, NE, and ABTX Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
The recent acquisition of Dicerna Pharmaceuticals makes Arrowhead Pharmaceuticals look like the next biotech in line to receive a juicy buyout offer.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates COR, STXB, BCML, DRNA; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / November 23, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: CoreSite Realty Corporation (NYSE:COR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to American Tower Corporation for $170.00 per share in cash.If you are a CoreSite shareholder, click here to learn more about your
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates DRNA, RRD, LEVL, HRC; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / November 22, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Novo Nordisk for $38.25 per share in cash. If you are a Dicerna shareholder, click here to learn more about your rights and
How Alnylam Pharmaceuticals Could Take On Pfizer With A 'Catalyst-Rich' 2022
Alnylam is working on a drug that could tackle transthyretin cardiomyopathy.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates COR, DRNA, STXB, BCML; Shareholders are Encouraged to Contact the Firm
/PRNewswire/ --Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: CoreSite Realty Corporation (NYSE:...
Novo Nordisk (NVO) Set to Acquire Dicerna for $3.3 Billion
Novo Nordisk (NVO) inks agreement to acquire Dicerna for $3.3 billion. The company is looking to boost its RNAi research platform with this acquisition.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Dicerna Pharmaceuticals, Inc.
/PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Dicerna...
Noteworthy Thursday Option Activity: DISCK, APO, DRNA
Dicerna Pharmaceuticals acquired by Novo Nordisk; Shares rocket 80%
Gottlieb said on CNBC's "Squawk Box" the fastest way to get more immunity into the population ahead of holiday season is a booster shot.
Why Dicerna Pharmaceuticals Stock Is Rocketing Higher Today
A juicy buyout offer from Novo Nordisk is giving Dicerna shareholders a big reason to cheer.
PTLO Stock: 8 Reasons Why Portillo’s Investors Feel Like Losing Their Lunch Today
Portillo's (PTLO) stock isn't doing so hot on Thursday and we're breaking down what has investors in the fast-food chain upset.
LCID, RIVN, FSR: Why Are EV Stocks Down Today?
We're taking a look at why EV stocks are down today and there are a couple of reasons shares of investors' favorites are falling.
Shareholder Alert: Ademi LLP investigates whether Dicerna Pharmaceuticals, Inc. has obtained a Fair Price in its going private transaction with Novo Nordisk
/PRNewswire/ -- Ademi LLP is investigating Dicerna (Nasdaq: DRNA), for possible breaches of fiduciary duty and other violations of law in its transaction with...
DRNA Stock: The $3B Novo Nordisk Deal That Has Dicerna Pharma Shares Skyrocketing Today
Dicerna Pharmaceuticals (DRNA) stock is surging higher on Thursday following news of a massive $3.3 billion deal with Novo Nordisk.
Dicerna Stock Rockets On Novo Nordisk's $3.3 Billion Takeover Plan
Novo Nordisk is buying an RNA interference company.